Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans.
about
Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South AfricaFunctional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosisHypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccinesResponse to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning.Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected childrenCerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic populationInterferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis?Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis.Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts.Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden countryThe proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic review.Impairment of IFN-gamma response to synthetic peptides of Mycobacterium tuberculosis in a 7-day whole blood assayCytotoxic mediators in paradoxical HIV-tuberculosis immune reconstitution inflammatory syndrome.Bioinformatic and empirical analysis of novel hypoxia-inducible targets of the human antituberculosis T cell responseHIV-1 and the immune response to TB.Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay.Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.Update in tuberculosis 2007.Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndromeNovel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistancePotent immune responses of Ag-specific Vgamma2Vdelta2+ T cells and CD8+ T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans.Tuberculosis and HIV-Needed: A New Paradigm for the Control and Management of Linked Epidemics.IFN-gamma release assays in tuberculosis management in selected high-risk populations.Diagnosing latent tuberculosis infection in the HIV era.Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.A 100 year update on diagnosis of tuberculosis infection.Tuberculosis assays: past, present and future.Interferon-gamma release assays for tuberculosis: current and future applications.Characterization of Mycobacterium tuberculosis-Specific Cells Using MHC Class II Tetramers Reveals Phenotypic Differences Related to HIV Infection and Tuberculosis Disease.Flow Cytometric Characterization of Antigen-Specific T Cells Based on RNA and Its Advantages in Detecting Infections and Immunological Disorders.Short-term reproducibility of a commercial interferon gamma release assay.Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.Quantiferon TB-Gold conversion can predict active tuberculosis development in elderly nursing home residents.Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell Responses.IFN-γ-release assays to diagnose TB infection in the immunocompromised individual
P2860
Q21261534-928C0C55-3B7D-46AF-9C1C-9A5E9FB15A49Q26849399-1777817B-0F03-4A69-B2C1-19CB403819C3Q28476626-B0DB123B-BFF5-4617-A8F0-0B8A25D4D9A9Q30840526-F3528E35-ACDA-41A6-B0A8-8A070BF7A93BQ33293104-01DFEA04-BA40-4BF8-A9E8-94D6DD89DDD9Q33411543-D357190C-5F5F-4E1A-A4AB-9C4F060F6B88Q33589272-B10D2414-5D8F-40BF-9B64-61700D73BB47Q34118528-2EE90D6C-6EE9-40F7-A78A-13640FEFBC85Q34137874-AF5FC433-C9F3-4285-8CA7-2B141F1705A2Q34159662-A4A1D89A-B6EF-4433-8E98-32E981F0602FQ34251506-FA9254BE-835B-4BB7-B9A7-CA781A25E985Q34512206-67D3009E-F87E-469B-B9B2-745646CE0D8BQ34575195-34CDEDE2-2BB0-4862-961F-71CEAE7E86A8Q34802722-2E068DA7-CC60-42AE-AFE4-7A3165B46A6AQ34949342-E4E9F860-31D8-4D09-9201-B9997D33EB96Q35056457-3A5CFD6A-36E3-4923-BDD7-C768726987C1Q36460197-FD7B699D-E8B5-47A4-9454-3C8127CD2B95Q36815449-89484F7F-ADC2-45AB-B6A5-75A3F7F50678Q36848581-6AE37CAF-235D-4966-A6F0-AC88FFA9B258Q36950190-F6E48AA2-CAF3-418E-B23D-37BD310B481DQ37093439-3502F8FA-B334-4FCB-B931-EC61E8D663FBQ37098501-AD700934-F9D1-4E5D-8FDE-4AE31148B476Q37331456-FCAE4BE6-DF75-4E73-9F0A-085560E1E3C4Q37344613-4CDCBD89-289B-45E1-B313-B9E53FD28F7EQ37379948-6E5E41DB-8BB2-4305-8E21-30D0B2D69BB0Q37418061-400D255B-CB6F-43FC-A1E4-9202CED752CFQ37431509-64C4F9D9-C5F4-4672-A602-2433F60D5F9BQ37461125-09FE9883-746E-45D0-99CF-3E1D00031846Q37635580-3ADD8E16-5B3A-4DF9-8DDF-BC208E7807F7Q37866817-9A771823-6921-47A5-837F-B0AB8434C7B9Q38168914-54B53646-79A7-451C-BC0A-EDBC95D96231Q38631641-6009BEFD-686C-4AA6-8016-7FD6E8F7D039Q41307773-E67AD3BA-623B-43FF-A4CF-3DE0E750A7FBQ43071927-93C8FD08-71E7-4765-A78C-FA5009576492Q45401374-6B558662-20A1-4E2D-9365-D8C2AC94E5C9Q48154595-F47F43E7-B477-439C-8E95-7EB50C5E3914Q52652836-2EC96090-AF97-4A8A-8CE9-138FE7BD81ACQ58924849-87C788F9-5E20-4DED-B6F6-CBC8F6EB72EE
P2860
Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Clinical, immunological, and e ...... nses in HIV-infected Africans.
@en
Clinical, immunological, and e ...... nses in HIV-infected Africans.
@nl
type
label
Clinical, immunological, and e ...... nses in HIV-infected Africans.
@en
Clinical, immunological, and e ...... nses in HIV-infected Africans.
@nl
prefLabel
Clinical, immunological, and e ...... nses in HIV-infected Africans.
@en
Clinical, immunological, and e ...... nses in HIV-infected Africans.
@nl
P2093
P2860
P50
P356
P1476
Clinical, immunological, and e ...... nses in HIV-infected Africans.
@en
P2093
Molebogeng X Rangaka
Priscilla Mouton
Ronnett Seldon
P2860
P304
P356
10.1086/518234
P407
P50
P577
2007-05-10T00:00:00Z